Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects.

Haiyin WuZhenquan HuangXuan WangMingyu ChenWei ChenYao HuaJian RenLuyao ShenYixuan SongYing ZhouChun-Xia LuoYuhui LinYilong WangLei ChangFei LiDong-Ya Zhu

Published in: Stroke and vascular neurology (2023)

ZL006-05 is a new neuroprotectant with fast-onset antidepressant and anxiolytic effects and has translational properties in terms of efficacy, safety and targeting of clinical issues.

Keyphrases

major depressive disorder
emergency department
stem cells
cancer therapy
bipolar disorder